248 related articles for article (PubMed ID: 25854796)
21. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
[TBL] [Abstract][Full Text] [Related]
22. β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.
Puymirat E; Riant E; Aissaoui N; Soria A; Ducrocq G; Coste P; Cottin Y; Aupetit JF; Bonnefoy E; Blanchard D; Cattan S; Steg G; Schiele F; Ferrières J; Juillière Y; Simon T; Danchin N
BMJ; 2016 Sep; 354():i4801. PubMed ID: 27650822
[TBL] [Abstract][Full Text] [Related]
23. Frequency of β-Blocker Use Following Exacerbations of COPD in Patients with Compelling Indication for Use.
Pinner N; Oliver W; Veasey T; Starr J; Eudaley S; Hutchison A; Wargo K
South Med J; 2019 Nov; 112(11):586-590. PubMed ID: 31682740
[TBL] [Abstract][Full Text] [Related]
24. Use and adherence to beta-blockers for secondary prevention of myocardial infarction: who is not getting the treatment?
Wei L; Flynn R; Murray GD; MacDonald TM
Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):761-6. PubMed ID: 15386713
[TBL] [Abstract][Full Text] [Related]
25. Discharge heart rate and mortality after acute myocardial infarction.
Seronde MF; Geha R; Puymirat E; Chaib A; Simon T; Berard L; Drouet E; Bataille V; Danchin N; Schiele F
Am J Med; 2014 Oct; 127(10):954-62. PubMed ID: 25004457
[TBL] [Abstract][Full Text] [Related]
26. Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.
Andersen SS; Hansen ML; Gislason GH; Folke F; Schramm TK; Fosbøl E; Sørensen R; Rasmussen S; Abildstrøm SZ; Madsen M; Køber L; Torp-Pedersen C
Cardiology; 2009; 112(2):144-50. PubMed ID: 18612201
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcome of acute myocardial infarction in patients on treatment with beta-blockers or calcium antagonists. A study of 7,922 hospitalized first myocardial infarctions.
Hansen O; Johansson BW; Gullberg B
Cardiology; 1992; 80(5-6):382-91. PubMed ID: 1360331
[TBL] [Abstract][Full Text] [Related]
28. Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD - Real-World Data from a Primary Care Setting.
Ellingsen J; Johansson G; Larsson K; Lisspers K; Malinovschi A; Ställberg B; Thuresson M; Janson C
Int J Chron Obstruct Pulmon Dis; 2020; 15():235-245. PubMed ID: 32099348
[TBL] [Abstract][Full Text] [Related]
29. Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study.
Mohammad MA; Andell P; Koul S; Desta L; Jernberg T; Omerovic E; Spaak J; Fröbert O; Jensen J; Engstrøm T; Hofman-Bang C; Persson H; Erlinge D
EuroIntervention; 2017 Jun; 13(2):e210-e218. PubMed ID: 28242589
[TBL] [Abstract][Full Text] [Related]
30. β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction.
Bao B; Ozasa N; Morimoto T; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Shiomi H; Tada T; Tazaki J; Kato Y; Hayano M; Natsuaki M; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T
Cardiovasc Interv Ther; 2013 Apr; 28(2):139-47. PubMed ID: 23054967
[TBL] [Abstract][Full Text] [Related]
31. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.
Krumholz HM; Radford MJ; Wang Y; Chen J; Heiat A; Marciniak TA
JAMA; 1998 Aug; 280(7):623-9. PubMed ID: 9718054
[TBL] [Abstract][Full Text] [Related]
32. Beta-blocker underuse in secondary prevention of myocardial infarction.
Everly MJ; Heaton PC; Cluxton RJ
Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
[TBL] [Abstract][Full Text] [Related]
33. Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
Yndigegn T; Lindahl B; Mars K; Alfredsson J; Benatar J; Brandin L; Erlinge D; Hallen O; Held C; Hjalmarsson P; Johansson P; Karlström P; Kellerth T; Marandi T; Ravn-Fischer A; Sundström J; Östlund O; Hofmann R; Jernberg T;
N Engl J Med; 2024 Apr; 390(15):1372-1381. PubMed ID: 38587241
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.
Zhang H; Yuan X; Zhang H; Chen S; Zhao Y; Hua K; Rao C; Wang W; Sun H; Hu S; Zheng Z
Circulation; 2015 Jun; 131(25):2194-201. PubMed ID: 25908770
[TBL] [Abstract][Full Text] [Related]
35. One-Year Landmark Analysis of the Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction.
Goldberger JJ; Subačius H; Marroquin OC; Beau SL; Simonson J;
J Am Heart Assoc; 2021 Jul; 10(14):e019017. PubMed ID: 34227397
[TBL] [Abstract][Full Text] [Related]
36. Effect of β-blockers on cardiac and pulmonary events and death in older adults with cardiovascular disease and chronic obstructive pulmonary disease.
Lee DS; Markwardt S; McAvay GJ; Gross CP; Goeres LM; Han L; Peduzzi P; Lin H; Dodson JA; Tinetti ME
Med Care; 2014 Mar; 52 Suppl 3(0 3):S45-51. PubMed ID: 24561758
[TBL] [Abstract][Full Text] [Related]
37. Long-term β-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study.
Kim J; Kang D; Park H; Kang M; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Gwon HC; Guallar E; Cho J; Hahn JY
Eur Heart J; 2020 Oct; 41(37):3521-3529. PubMed ID: 32542362
[TBL] [Abstract][Full Text] [Related]
38. Use of beta-blocker is associated with lower mortality in patients with coronary artery disease with or without COPD.
Rezaei SS; Rinner C; Ratajczak P; Grossmann W; Gall W; Wolzt M
Clin Respir J; 2018 Dec; 12(12):2627-2634. PubMed ID: 30276967
[TBL] [Abstract][Full Text] [Related]
39. Temporal Trends in Treatment and Outcomes of Acute Myocardial Infarction in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Observational Study.
Su TH; Chang SH; Chen PC; Chan YL
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28298371
[TBL] [Abstract][Full Text] [Related]
40. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
